Skip to content

Multicentre closed-loop home study in young people with type 1 diabetes

Multicentre closed-loop home study in young people with type 1 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24960600
Enrollment
24
Registered
2014-01-16
Start date
2013-12-10
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Diabetes Research Network, Medicines for Children Research Network

Interventions

1. Realtime CGM + overnight CL 2. Realtime CGM alone

Sponsors

Cambridge University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subject is between 6 and 18 years of age (inclusive) 2. The subject has type 1 diabetes, as defined by WHO for at least 1 year or is confirmed Cpeptide negative 3. The subject will have been an insulin pump user for at least 3 months, with good knowledge of insulin selfadjustment as judged by theinvestigator. 4. The subject is willing to perform regular fingerprick blood glucose monitoring, with at least 4 blood glucose measurements taken every day 5. HbA1c = 10 % based on analysis from central laboratory or equivalent 6. The subject is literate in English

Exclusion criteria

Exclusion criteria: 1. Known or suspected allergy against insulin 2. Nontype 1 diabetes mellitus including those secondary to chronic disease 3. Untreated celiac disease 4. Any other physical or psychological disease likely to interfere with the normal conduct of the study and interpretation of the study results as judged by the investigator 5. Current treatment with drugs known to interfere with glucose metabolism, eg systemic corticosteroids, nonselective betablockers and MAO inhibitors etc 6. Known or suspected allergy against insulin 7. Subjects with clinical significant nephropathy, neuropathy or proliferative retinopathy as judged by the investigator 8. Total daily insulin dose = 2 IU/kg/day 9. Total daily insulin dose < 10 IU/day 10. Pregnancy, planned pregnancy, or breast feeding 11. Severe visual impairment 12. Severe hearing impairment 13. Subjects using implanted internal pacemaker

Design outcomes

Primary

MeasureTime frame
Time spent overnight in the target glucose range (3.9 to 8.0 mmol/l)

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026